Author:
Chen Tai-Li,Ma Sheng-Hsiang
Reference5 articles.
1. Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study;Hasan;J Am Acad Dermatol,2024
2. T cells in the skin: lymphoma and inflammatory skin disease;Roediger;J Allergy Clin Immunol,2022
3. Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study;Nguyen;Arch Dermatol Res,2023
4. Molecular pathogenesis of Cutaneous T cell Lymphoma: role of chemokines, cytokines, and dysregulated signaling pathways;Patil;Semin Cancer Biol,2022
5. Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation;Le Floc'h;Allergy,2020